Effect of beta-adrenergic stimulation on myocardial adenine nucleotide metabolism.
D000227:Adenine Nucleotides / Q000378:metabolism*; D000244:Adenosine Diphosphate / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism; D000249:Adenosine Monophosphate / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000032:analysis / Q000096:biosynthesis / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000037:antagonists & inhibitors; D002250:Carbon Radioisotopes; D004357:Drug Synergism; D005246:Feedback; D005260:Female; D005998:Glycine / Q000378:metabolism; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D007545:Isoproterenol / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology; D007700:Kinetics; D009206:Myocardium / Q000032:analysis / Q000378:metabolism; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology; D051381:Rats; D013997:Time Factors; D014700:Verapamil / Q000031:analogs & derivatives / Q000494:pharmacology
D000227:Adenine Nucleotides; D000319:Adrenergic beta-Antagonists; D002250:Carbon Radioisotopes; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D011433:Propranolol; D014700:Verapamil; D007545:Isoproterenol; D002118:Calcium; D005998:Glycine